Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Default user image.

Carola Tilgmann

Driftchef

Default user image.

Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion

Författare

  • Teemu Helkamaa
  • Ilkka Reenilä
  • Raimo K. Tuominen
  • Seppo Soinila
  • Antti Väänänen
  • Carola Tilgmann
  • Pekka Rauhala

Summary, in English

Activated microglial cells are found in the substantia nigra and the striatum of Parkinson's disease patients. These cells have been shown to express catechol-O-methyltransferase activity which may increase during pathological conditions. Lipopolysaccharides are potent activators of microglial cells. After paranigral lipopolysaccharide infusion to rats we observed intense microglial activation around the lesion area followed by a delayed injury in nigrostriatal pathway in 2 weeks. Simultaneously, catechol-O-methyltransferase activity in the substantia nigra was gradually increased up to 213%. In the Western blot the amount of soluble COMT and membrane bound COMT proteins were increased by 255% and 86%, respectively. Increased catechol-O-methyltransferase immunoreactivity was located primarily into the activated microglial cells in the lesion area. Interestingly, catechol-O-methyltransferase and OX-42 stained also intensively microglia/macrophage-like cells which surrounded the adjacent blood vessels. Inhibition of catechol-O-methyltransferase activity by tolcapone or entacapone did not increase lipopolysaccharide-induced neurotoxicity. We conclude that catechol-O-methyltransferase activity and protein expression were increased in the substantia nigra after inflammation induced by lipopolysaccharides. These changes in glial and perivascular catechol-O-methyltransferase activity may have clinical relevance for Parkinson's disease drug treatment due to increased metabolism of levodopa in the brain.

Publiceringsår

2007-11

Språk

Engelska

Sidor

412-423

Publikation/Tidskrift/Serie

Neurochemistry International

Volym

51

Issue

6-7

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Nyckelord

  • Catechol-O-methyltransferase
  • Dopamine
  • l-Dopa
  • Lipopolysaccharide
  • Microglia
  • OX-42
  • Parkinson's disease
  • Substantia nigra

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 0197-0186